<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04792424</url>
  </required_header>
  <id_info>
    <org_study_id>IRB No.35/2564</org_study_id>
    <nct_id>NCT04792424</nct_id>
  </id_info>
  <brief_title>No Monitoring of Post-filter Ionized Calcium in Regional Citrate Anticoagulation</brief_title>
  <official_title>No Monitoring of Post-filter Ionized Calcium in Regional Citrate Anticoagulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Do no monitor of post-circuit ionized calcium affact the filter life time of continueous&#xD;
      renal replacement therapy with regional citrate anticoagulation circuit? A randomized control&#xD;
      trial&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Regional citrate anticoagulation is the gold standard of anticoagulation in patient receiving&#xD;
      CRRT. In RCA circuit, there was a monitoring of pre-filter (systemic) ionized calcium and&#xD;
      post-filter (circuit) ionized calcium. Pre-filter ionized calcium was monitored for observe&#xD;
      the adverse effect of citrate such as hypocalcemia, citrate intoxication. However,&#xD;
      post-filter ionized calcium was monitored for adjustment the citrate dose. We find many&#xD;
      problem with frequently monitoring of post-ionized calcium such as confusion from markedly&#xD;
      abnormal result, how to adjustment the citrate dose ,and increase workload for nurses. We&#xD;
      hypothesis that if we can monitoring of post-filter ionized calcium?&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
    <masking_description>Masking of post-filter ionized calcium result in no-monitoring arm</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Filter lifetime in hours</measure>
    <time_frame>72 hours</time_frame>
    <description>How long with filter with RCA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse event</measure>
    <time_frame>72 hours</time_frame>
    <description>adverse event of RCA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Circuit downtime in hours</measure>
    <time_frame>72 hours</time_frame>
    <description>Circuit downtime during CRRT with RCA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost per treatment in Baht</measure>
    <time_frame>72 hour</time_frame>
    <description>Cost of CRRT include laboratory in Baht</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Citrate accumulation</measure>
    <time_frame>72 hours</time_frame>
    <description>Number of total calcium to ionized calcium ratio &gt; 2.5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy of CRRT</measure>
    <time_frame>72 hours</time_frame>
    <description>Seiving coefficient of urea and difference of prescribed dose of CRRT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Citrate dose</measure>
    <time_frame>72 hours</time_frame>
    <description>Average citrate dose</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change of SOFA scores</measure>
    <time_frame>72 hours</time_frame>
    <description>Change of SOFA Scores (Use the worst value in 24 hour) from baseline to end of the study</description>
  </other_outcome>
  <other_outcome>
    <measure>Change of APACHE II score</measure>
    <time_frame>72 hours</time_frame>
    <description>Change of APACHE II score (Use the worst value in 24 hour)from baseline to end of the study</description>
  </other_outcome>
  <other_outcome>
    <measure>Change of Hct</measure>
    <time_frame>72 hours</time_frame>
    <description>Rate of Hct change from from baseline to end of the study</description>
  </other_outcome>
  <other_outcome>
    <measure>Change of electrolyte</measure>
    <time_frame>72 hours</time_frame>
    <description>Rate of electrolyte change from baseline to end of the study</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Regional Citrate Anticoagulation</condition>
  <condition>Ionized Calcium</condition>
  <condition>Continuous Renal Replacement Therapy</condition>
  <arm_group>
    <arm_group_label>No monitoring of post filter ionized calcium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Starting dialysis with continuous renal replacement therapy with regional citrate anticoagulation.&#xD;
Patients will receive standard treatments such as anti-bacterial agents, mechanical ventilator, vasopressors as appropriate.&#xD;
Citrate dose start at 4 mmol/L and no adjustment of citrate dose. Post-filter ionized calcium result will blind for physician.&#xD;
Other laboratory such as pre-filter ionized calcium, electrolyte, ABG, calcium, the ratio of total calcium to systemic ionized calcium will monitor every 8 hour.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Monitoring of post filter ionized calcium</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Starting dialysis with continuous renal replacement therapy with regional citrate anticoagulation.&#xD;
Patients will receive standard treatments such as anti-bacterial agents, mechanical ventilator, vasopressors as appropriate.&#xD;
Citrate dose start at 4 mmol/L with adjustment of citrate dose to acheive post-filter ionized calcium at 0.25-0.35 mmol/L.&#xD;
Other laboratory such as pre-filter ionized calcium, electrolyte, ABG, calcium, the ratio of total calcium to systemic ionized calcium will monitor every 8 hour.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Regional citrate anticoagulation</intervention_name>
    <description>Starting RCA 4 mmol/L (adjust the rate by BFR)</description>
    <arm_group_label>Monitoring of post filter ionized calcium</arm_group_label>
    <arm_group_label>No monitoring of post filter ionized calcium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vasopressor</intervention_name>
    <description>Vasopressors such as Norepinephrine, dopamine, milrinone, dobutamine</description>
    <arm_group_label>Monitoring of post filter ionized calcium</arm_group_label>
    <arm_group_label>No monitoring of post filter ionized calcium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antibiotic</intervention_name>
    <description>Antibacterial agents deemed appropriate by physicians in the ICU</description>
    <arm_group_label>Monitoring of post filter ionized calcium</arm_group_label>
    <arm_group_label>No monitoring of post filter ionized calcium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dialysis with continuous renal replacement therapy</intervention_name>
    <description>Prismaflex</description>
    <arm_group_label>Monitoring of post filter ionized calcium</arm_group_label>
    <arm_group_label>No monitoring of post filter ionized calcium</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age older than 18 years old and admission in an ICU&#xD;
&#xD;
          -  Indication for CRRT&#xD;
&#xD;
          -  regional citrate anticoagulation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute liver failure defined as AST or ALT &gt; 5X UNL or TB/DB &gt; 5X UNL or evidence of&#xD;
             cirrhosis&#xD;
&#xD;
          -  Severe persistent lactic acidosis (lactate persist &gt; 8 mg/dL consecutively within 6&#xD;
             hours)&#xD;
&#xD;
          -  Receiving heparin anticoagulation&#xD;
&#xD;
          -  Severe alkalosis (pH&gt;7.55) or acidosis (pH&lt;7.1)&#xD;
&#xD;
          -  History of renal allograft&#xD;
&#xD;
          -  Known pregnancy&#xD;
&#xD;
          -  Patient is moribund with expected death within 24 hr&#xD;
&#xD;
          -  Deficiency of ionzed calcium (Cation &lt; 0.8 mmol/L)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nattachai Srisawat, MD</last_name>
    <phone>6622564000</phone>
    <phone_ext>3597</phone_ext>
    <email>drnattachai@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Peerapat Thanapongsatorn, MD</last_name>
    <phone>66837076440</phone>
    <email>peerapat.manu@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chulalongkorn university</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nattachai Srisawat, MD</last_name>
      <phone>6622564000</phone>
      <phone_ext>3597</phone_ext>
      <email>drnattachai@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Sasithorn Kunupakan, MD</last_name>
      <phone>66831999741</phone>
      <email>nonghui2010@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>March 3, 2021</study_first_submitted>
  <study_first_submitted_qc>March 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2021</study_first_posted>
  <last_update_submitted>June 9, 2021</last_update_submitted>
  <last_update_submitted_qc>June 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Nattachai Srisawat ,M.D.</investigator_full_name>
    <investigator_title>Director of Excellence Center for Critical Care Nephrology</investigator_title>
  </responsible_party>
  <keyword>Regional citrate anticoagulation</keyword>
  <keyword>Ionized calcium</keyword>
  <keyword>Continuous Renal Replacement Therapy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Vasoconstrictor Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

